From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus Infections

Objective: There is currently no effective medicine or supplement for clearance of high risk- human papillomavirus (HR-HPV) infections. We have taken a systematic approach evaluating the potential use of AHCC supplementation to support clearance of HR-HPV infections. The primary objective of this re...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Judith A., Mathew, Lata, Gaikwad, Anjali, Rech, Barbara, Burney, Maryam N., Faro, Jonathan P., Lucci, Joseph A., Bai, Yu, Olsen, Randall J., Byrd, Teresa T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435520/
https://www.ncbi.nlm.nih.gov/pubmed/30949451
http://dx.doi.org/10.3389/fonc.2019.00173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435520/
https://www.ncbi.nlm.nih.gov/pubmed/30949451
http://dx.doi.org/10.3389/fonc.2019.00173

Ejemplares similares